A fundamental function of The Children's Hospital at Downstate is to improve the health of newborns and children through innovative cutting edge research on the molecular basis of childhood disease and novel pharmacologic therapies and other effective interventions. Research scientists in the Department of Pediatrics and the College of Medicine are working together to investigate causes of childhood illnesses. Downstate researchers through the support from the NIH, foundations and pharmaceutical companies continue to develop innovative techniques and novel therapies for treating and diagnosing a wide range of childhood illnesses. Evaluation and application of emerging technologies have the potential to offer exciting breakthroughs for preventing and treating disease.
The Children's Hospital at Downstate is also a sub-site for the NIH Pediatric Pharmacology Research Unit (PPRU) whose major mission is to study the pharmacologic basis of drug therapies during development, drug metabolism and disposition and appropriate dose regimens in newborns and children. Clinical research teams at the Children's Hospital foster the implementation of investigator initiated studies as well as participation in multi-center trials.